Lipid Composition for Preterm Infant Catch-Up Growth
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Preterm and small for gestational age infants often experience excessive catch-up growth, leading to increased risk of obesity and metabolic disorders due to excessive adipose tissue deposition, particularly visceral adipose tissue, which existing nutritional formulas fail to adequately address.
Innovation Solution
A nutritional composition comprising large lipid globules or phospholipid-coated lipid globules, with a volume-weighted mode diameter of at least 1.0 μm and a phospholipid content of at least 0.5 wt. % based on total lipid, is administered to promote controlled catch-up growth, reducing visceral adipose tissue while increasing subcutaneous adipose tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If standard infant formula with small lipid globules is administered to preterm or SGA infants, then catch-up growth is promoted, but excessive visceral adipose tissue is deposited leading to increased obesity risk
Solution Approach 1:
The patent applies local quality by differentiating the properties of lipid globules based on their size and phospholipid coating. Large lipid globules (≥1.0 μm) with phospholipid coating (≥0.5 wt.%) are specifically designed to be preferentially deposited in subcutaneous adipose tissue, while small lipid globules are directed toward visceral adipose tissue. This creates localized differences in lipid deposition quality, ensuring that growth-promoting lipids are deposited in the safer subcutaneous compartment rather than the harmful visceral compartment.
Solution Approach 2:
The patent changes critical parameters of the lipid emulsion including globule size (volume-weighted mode diameter ≥1.0 μm), phospholipid content (≥0.5 wt.% based on total lipid), and globule size distribution. These parameter changes transform the lipid delivery system from one that uniformly deposits lipids in both visceral and subcutaneous compartments to one that selectively deposits in subcutaneous tissue, thereby resolving the contradiction between promoting growth and preventing harmful visceral fat accumulation.
2Productivity
If higher energy and protein content formula is used to enable increased growth rate, then catch-up growth is enhanced, but excessive adipose tissue mass is formed
Solution Approach 1:
The patent applies local quality by directing different quantities of lipids to different adipose tissue depots based on globule size. Large lipid globules with phospholipid coating are preferentially stored in subcutaneous adipose tissue, which can accommodate excess energy without harmful metabolic consequences. This spatial differentiation allows the formula to provide high energy content for growth while preventing harmful accumulation in visceral adipose tissue.
Solution Approach 2:
The patent uses phospholipid-coated large lipid globules as an intermediary mechanism to mediate between energy intake and adipose tissue deposition. The phospholipid coating on large globules acts as a marker or signal that directs these lipids specifically to subcutaneous adipose tissue macrophages for storage, thereby intermediating the pathway between dietary energy and safe energy storage, preventing direct deposition in visceral tissue.
3Productivity
If rapid catch-up growth is promoted in preterm or SGA infants, then growth retardation is compensated, but future obesity and type 2 diabetes risk increases
Solution Approach 1:
The patent applies local quality by creating distinct lipid deposition patterns in different adipose tissue compartments. By ensuring that the majority of lipid energy is deposited in subcutaneous adipose tissue rather than visceral adipose tissue, the formula promotes healthy catch-up growth while preventing the metabolic disturbances associated with visceral obesity, thereby reducing future diabetes risk.
Solution Approach 2:
The patent converts the potentially harmful effect of rapid catch-up growth into a beneficial outcome by redirecting lipid deposition away from harmful visceral tissue toward beneficial subcutaneous tissue. The high energy content that would normally lead to harmful visceral fat accumulation and metabolic disorders is instead channeled into safe subcutaneous storage, transforming a harmful process into a beneficial one.
Data Source
AI summary
The invention relates to nutritional compositions comprising specifically designed lipid globules that are especially suited for preterm infants, small for gestational age infants and infants with retarded growth due to physical or mental stress after birth, for promoting catch-up growth and/or for use in improving body composition, improving adipose tissue distribution, decreasing visceral adipose tissue based on body weight and/or on total adipose tissue, and/or decreasing the ratio visceral adipose tissue to subcutaneous adipose tissue, in such infants, and/or providing nutrition to such infants.